Retrospective Survey of Bone Fracture in Patients With Arimidex 1mg

Study to Determine Treatment Effects of Denosumab in Patients With Breast Cancer Receiving Aromatase Inhibitor Therapy

NCT00556374 ·Status: COMPLETED ·Phase: PHASE3

Do Aromatase Inhibitors (AIs) Decrease Intestinal Calcium Absorption?

NCT00766532 ·Status: COMPLETED ·Phase: PHASE4

Survey Conducted Among Early Breast Cancer Patients Treated With Arimidex for Evaluation of Treatment Adherence

NCT01081509 ·Status: COMPLETED

Arthralgia During Anastrozole Therapy for Breast Cancer

NCT00323479 ·Status: COMPLETED ·Phase: PHASE4

Evaluating The Safety Of Exemestane Following 2-3 Years Of Adjuvant Tamoxifen Therapy In Postmenopausal Early Breast Cancer Patients

NCT01155063 ·Status: TERMINATED

Evaluation of Blood/Imaging Based Biomarkers, Aromatase Inhibitor Induced Musculoskeletal Syndrome

NCT03665077 ·Status: COMPLETED ·Phase: NA

Evaluation of Predictive Factors Regarding the Effectivity of Aromatase Inhibitor Therapy (PreFace)

NCT01908556 ·Status: UNKNOWN ·Phase: PHASE4

Arimidex Observational: Reason for and Effect of Change From Tamoxifen

NCT00246961 ·Status: COMPLETED

Effectiveness of Combination of Arimidex and Nolvadex in Adjuvant Therapy of Breast Carcinoma in Postmenopausal Women.

NCT00287534 ·Status: COMPLETED ·Phase: PHASE2

Study of Arimidex and Radiotherapy Sequencing

NCT01402193 ·Status: UNKNOWN ·Phase: PHASE3

Aromasin Vs Arimidex Study As Initial Hormonal Therapy In Postmenopausal Women With Advanced/Recurrent Breast Cancer

NCT00143390 ·Status: COMPLETED ·Phase: PHASE3

Anastrozole and Letrozole

NCT00762294 ·Status: COMPLETED

Evaluation of the Relationship of TOP2α Expression and Effect of Non Dose-dense Chemotherapy for Breast Cancer

NCT02506361 ·Status: RECRUITING

Open-Label Study Of Exemestane With Or Without Celecoxib In Postmenopausal Women With ABC Having Progressed On Tamoxifen

NCT00038103 ·Status: COMPLETED ·Phase: PHASE2

Effects of Arzoxifene on Bone Fractures and Incidence of Breast Cancer

NCT00088010 ·Status: COMPLETED ·Phase: PHASE3

Breast Density, Hormone Levels, and Anticancer Drug Levels in Women With Invasive Breast Cancer Who Are Receiving Exemestane or Anastrozole

NCT00316836 ·Status: COMPLETED

Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast Cancer

NCT02598557 ·Status: COMPLETED ·Phase: PHASE2

Studying the Effect of Denosumab on Preventing Breast Cancer in Women With a BRCA1 Germline Mutation

NCT04711109 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer

NCT02246621 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Tamoxifen to Prevent Bone Loss and Heart Disease in Premenopausal Women Receiving Chemotherapy for Stage I or Stage II Breast Cancer

NCT00005605 ·Status: COMPLETED

Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer

NCT00516698 ·Status: COMPLETED

Effect of Aromatase Inhibitors on Bones and Genes

NCT00603967 ·Status: COMPLETED ·Phase: NA

Breast Cancer Women on Aromatase Inhibitors Treatment

NCT03811509 ·Status: UNKNOWN ·Phase: PHASE4

Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer

NCT05941520 ·Status: RECRUITING ·Phase: PHASE2

Effect of Tamoxifen or an Aromatase Inhibitor on Estrogen Metabolism in Women Treated for Newly Diagnosed Breast Cancer

NCT00569543 ·Status: COMPLETED